Autopsy cases of fulminant bacterial infection in adults: Clinical onset depends on the virulence of bacteria and patient immune status

Journal of Infection and Chemotherapy

Volumn 18, Issue 5, 2012, Pages 637-645

  Tajiri, Takuma ^a   Tate, Genshu ^a   Masunaga, Atsuko ^a   Miura, Katsutoshi ^b   Masuda, Shinji ^c   Kunimura, Toshiaki ^d   Mitsuya, Toshiyuki ^a   Morohoshi, Toshio ^e  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Koseiren Takaoka Hospital   (Japan)

^d SHOWA UNIVERSITY NORTHERN YOKOHAMA HOSPITAL   (Japan)

^e SHOWA UNIVERSITY   (Japan)

Author keywords

Autopsy; Circulatory collapse; Host defence system; Onset of fulminant bacterial infection

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; AUTOPSY; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BLOOD CULTURE; CAUSE OF DEATH; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FULMINANT BACTERIAL INFECTION; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; HUMAN TISSUE; HYPOTENSION; IMMUNE STATUS; LABORATORY TEST; LIMB PAIN; LUNG CONGESTION; MALE; MULTIPLE ORGAN FAILURE; NECROTIZING FASCIITIS; NONHUMAN; SEPTIC SHOCK;

EID: 84871398511     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0384-9     Document Type: Article

References (43)

1. Takahashi T, Sunaoshi K, Sunakawa K, Fujishima S, Watanabe H, Invasive Streptococcal Disease Working Group. Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp. equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections. Clin Microbiol Infect. 2010;16:1097-103.
2. Takahashi T, Asami R, Tanabe K, Hirono Y, Nozawa Y, Chiba N, et al. Clinical aspects of invasive infection with Streptococcus dysgalactiae subsp. equisimilis in elderly patients. J Infect Chemother. 2010;16:68-71.
3. Broyles LN, Beneden CV, Beall B, Facklam R, Shewmaker PL, Malpiedi P, et al. Population-based study of invasive disease due to a-hemolytic streptococci of groups other than A and B. Clin Infect Dis. 2009;48:706-12.
4. Blake PA, Merson MH, Weaver RE, Hollis DG, Heublein PC. Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med. 1979;300:1-5.
5. Kaul R, McGeer A, Low DE, Green K, Schwartz B. Populationbased surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med. 1997;103:18-24.
6. Waghorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol. 2001;54:214-8.
7. Hlady WG, Mullen RC, Hopkin RS. Vibrio vulnificus from raw oysters. Leading cause of reported deaths from foodborne illness in Florida. J Fla Med Assoc. 1993;80:536-8.
8. Tajiri T, Tate G, Miura K, Masuda S, Ohike N, Kunimuta T, et al. Sudden death caused by fulminant bacterial infection: background and pathogenesis of Japanese adult cases. Intern Med. 2008;47:1499-504.
9. Norrby-Teglund A, Thulin P, Gan BS, Kotb M, McGeer A, Andersson J, et al. Evidence for superantigen involvement in severe group a streptococcal tissue infections. J Infect Dis. 2001;184:853-60.
10. Espat NJ, Auffenberg T, Abouhamze A, Baumhofer J, Moldawer LL, Howard RJ. A role for tumor necrosis factor-alpha in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction. Ann Surg. 1996;223:428-33.
11. Shin SH, Shin DH, Ryu PY, Chung SS, Rhee JH. Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients' sera. FEMS Immunol Med Microbiol. 2002;33:133-8.
12. Coonrod JD, Leach RP. Antigenemia in fulminant pneumococcemia. Ann Intern Med. 1976;84:561-3.
13. Rytel MW, Dee TH, Ferstenfeld JE, Hensley GT. Possible pathogenetic role of capsular antigens in fulminant pneumococcal disease with disseminated intravascular coagulation (DIC). Am J Med. 1974;57:889-96.
14. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA. 1993;269:390-1.
15. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996;335:547-54.
16. Greipp PR, Miguel JS, Durie BGM, Crowly JJ, Barlogie B, Blade J, et al. International staging system for multiple myeloma. J Clin Oncol. 2005;15:3412-20.
17. Bone RC, Fein AM, Balk RA, Knaus WA, Cerra FB, Schein RMH, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644-55.
18. Chuang YY, Huang YC, Lin TZ. Toxic shock syndrome in children: epidemiology, pathogenesis, and management. Paediatr Drugs. 2005;7:11-25.
19. Davis JP, Chesney PJ, Wand PJ, Laventure M, Investigation and Laboratory Team. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors and prevention. N Engl J Med. 1980;303:1429-35.
20. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989;321:1-7.
21. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA. 1993;269:384-9.
22. Shimizu Y, Ohyama A, Kasama K, Miyazaki M, Ooe K, Ookochi Y. Case report of toxic shock-like syndrome due to group A streptococcal infection. Kansenshogaku Zasshi. 1993;67:236-9 (in Japanese with English abstract
23. Brandt CM, Spellerberg B. Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis. 2009;49:766-72.
24. Tajiri T, Tate G, Akita H, Ohike N, Masunaga A, Kunimura T, et al. Autopsy cases of fulminant-type bacterial infection with necrotizing fasciitis: group A (beta) hemolytic Streptococcus pyogenes versus Vibrio vulnificus infection. Pathol Int. 2008;57:606-12.
25. Sie MY, Ip-yam PC, Oon LL. Vibrio vulnificus septicaemia. Anaesth Intensive Care. 2002;30:77-81.
26. Matsumoto K, Ohshige K, Fujita N, Tomita Y, Matsumoto S, Nakashima M, et al. Clinical features of Vibrio vulnificus infections in the coastal areas of the Ariake Sea, Japan. J Infect Chemother. 2010;16:272-9.
27. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. BMJ. 1996;312:430-4.
28. Cullingford GL, Watkins DN, Watts AD, Mallon DF. Severe late postsplenectomy infection. Br J Surg. 1991;78:716-21.
29. Gowda R, Razvi FM, Summerfield GP. Risk of pneumococcal septicaemia in patients with chronic lymphoproliferative malignancies. BMJ. 1995;311:26-7.
30. Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect. 2001;43:182-6.
31. Tajiri T, Tate G, Enosawa T, Akita H, Ohike N, Masunaga A, et al. Clinicopathological findings in fulminant-type pneumococcal infection: report of three autopsy cases. Pathol Int. 2007;57:606-12.
32. Barry W, Hudgins L, Donta ST, Pesanti EL. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA. 1992;267: 3315-6.
33. Norrby-Teglund A, Muller MP, Mcgeer A, Gan BS, Guru V, Bohnen J, et al. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis. 2005;37:166-72.
34. Ato M, Ikebe T, Kawabata H, Takemori T, Watanabe H. Incompetence of neutrophils to invasive group A Streptococcus is attributed to induction of plural virulence factors by dysfunction of a regulator. PLoS One. 2008;3:e3455.
35. Ikebe T, Ato M, Matsumura T, Hasegawa H, Sata T, Kobayashi K, et al. Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates. PLoS Pathog. 2010;6:e1000832.
36. Ikebe T, Murayama S, Saitoh K, Yanai S, Suzuki R, Isobe J, et al. Surveillance of severe invasive group-G streptococcal infections and molecular typing of the isolates in Japan. Epidemiol Infect. 2004;132:145-9.
37. Hidalgo-Grass C, Dan-Goor M, Maly A, Eran Y, Kwinn LA, Nizet V, et al. Effect of a bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotizing softtissue. Lancet. 2004;363:696-703.
38. Lahnborg G, Friman L, Berghem L. Reticuloendothelial function in patients with alcoholic liver cirrhosis. Scand J Gastroenterol. 1981;16:481-9.
39. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology. 1984;4:53-8.
40. Hor LI, Chang YK, Chang CC, Lei HY, Ou JT. Mechanism of high susceptibility of iron-overloaded mouse to Vibrio vulnificus infection. Microbiol Immunol. 2000;44:871-8.
41. Bullen JJ, Spalding PB, Ward CG, Gutteridge JMC. Hemochromatosis, iron, and septicemia caused by Vibrio vulnificus. Arch Intern Med. 1991;151:1606-9.
42. Prasad US, Walker WS, Sang CT, Campanella C, Cameron EW. Influence of obesity on the early and long term results of surgery for coronary artery disease. Eur J Cardiothorac Surg. 1991;5:67-72.
43. Jugenburg M, Haddock G, Freedman MH, Ford-Jones L, Ein SH. The morbidity and mortality of pediatric splenectomy: does prophylaxis make a differenceJ Pediatr Surg. 1999;34:1064-7.